CYD
China Yuchai International Limited
There isn't enough reported data to score CYD yet.
RKLB
Rocket Lab USA, Inc.
RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
CYD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Strong |
CYD's profitability and balance sheet are currently strong. There isn't enough data to rate its revenue and cash flow.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CYD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.6x | $8.12 | -62% |
| Fair | 9.7x | $11.88 | -44% |
| Current | 17x | $21.15 | — |
| Expensive | 23x | $28.76 | +36% |
Historical ranges are pointers, not guarantees.
CYD's PE is 17x, but its earnings don't support one, so it isn't a reliable read right now.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
CYD Forward outlook
There aren't enough analyst estimates for CYD to show an outlook.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CYD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | $1.23 | +17% |
| Q4 2023 | $1.05 | +31% |
| Q4 2022 | $0.80 | -20% |
| Q4 2021 | $1.00 | -50% |
| Q4 2020 | $2.02 | -9% |
| Q4 2019 | $2.22 | -13% |
| Q4 2018 | $2.55 | -27% |
| Q4 2017 | $3.51 | +82% |
CYD has the edge over RKLB in the latest year-over-year earnings comparison.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
CYD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $2.9B | +6% |
| Q4 2023 | $2.7B | +13% |
| Q4 2022 | $2.4B | -25% |
| Q4 2021 | $3.2B | +3.3% |
| Q4 2020 | $3.1B | +14% |
| Q4 2019 | $2.7B | +11% |
| Q4 2018 | $2.4B | +0.3% |
| Q4 2017 | $2.4B | +334% |
CYD's revenue is growing: $2.9B last quarter, down 7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | 3.1% | -2.6 points |
| Q4 2023 | 3.4% | -3 points |
| Q4 2022 | 3.2% | -4.6 points |
| Q4 2021 | 3.1% | -7.5 points |
| Q4 2020 | 5.7% | -4.4 points |
| Q4 2019 | 6.4% | +0.8 points |
| Q4 2018 | 7.9% | +1.3 points |
| Q4 2017 | 11% | +5.1 points |
CYD's operating margin was 3.1% last quarter, down 2.6 points from the same quarter a year ago, near the bottom of its range since 2015.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over CYD in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
CYD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | $62.9M | -58% |
| Q4 2023 | $148.3M | +$230.9M |
| Q4 2022 | -$82.6M | -$72.5M |
| Q4 2021 | -$10.1M | -108% |
| Q4 2020 | $124.7M | -0.4% |
| Q4 2019 | $125.1M | +217% |
| Q4 2018 | $39.4M | -76% |
| Q4 2017 | $162.2M | +$162.2M |
CYD still generates free cash flow, though less than at its 2017 peak: $118M over the past year.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
CYD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.8% | -1.5M shares |
| 1 year | -3.8% | -1.5M shares |
| 3 years | 0% | -10.2K shares |
CYD has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $42.9M |
| Q4 2016 | — |
| Q3 2016 | — |
| Q2 2016 | — |
| Q1 2016 | — |
| Q4 2015 | — |
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CYD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -2.6x | Net Cash |
| Q4 2023 | -2.4x | Net Cash |
| Q4 2022 | -1.8x | Net Cash |
| Q4 2021 | -2.1x | Net Cash |
| Q4 2020 | -2.2x | Net Cash |
| Q4 2019 | -0.9x | Net Cash |
| Q4 2018 | -2.1x | Net Cash |
| Q4 2017 | -1.7x | Net Cash |
CYD has more cash than debt.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CYD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.2 | Oversold |
| Stochastic | 2.4 | Oversold |
CYD's weekly RSI is 25 (oversold) and its Stochastic is 2 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
CYD PE vs Industrials Sector
| Metric | CYD | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 24x | 29% below |
| PE % | 78 | 58 | 20 pts above |
CYD is trading at 17x earnings, a 29% discount to the Industrials sector's median of 24x, though its earnings don't support one.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
CYD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.0 | 19% below |
| 20 week MA | $35.6 | 41% below |
| 50 week MA | $41.1 | 49% below |
| 100 week MA | $32.2 | 34% below |
| 200 week MA | $20.8 | 1.7% above |
CYD has fallen below most of its moving averages, though it's still 1.7% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over CYD on trend strength, trading above more of its moving averages.
CYD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.4 | $16.5 | +23% |
| 2021 | $16.5 | $11.0 | -33% |
| 2022 | $11.0 | $7.10 | -36% |
| 2023 | $7.10 | $8.38 | +18% |
| 2024 | $8.38 | $11.1 | +32% |
| 2025 | $11.1 | $35.9 | +224% |
| 2026 YTD | $35.9 | $21.2 | -41% |
CYD is down 41% so far in 2026, after finishing higher in four of the previous six years.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over CYD on returns for 2026, with the stronger performance.